Last reviewed · How we verify
Targeted CEA CAR-T — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Targeted CEA CAR-T (Targeted CEA CAR-T) — Chongqing Precision Biotech Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Targeted CEA CAR-T TARGET | Targeted CEA CAR-T | Chongqing Precision Biotech Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Targeted CEA CAR-T CI watch — RSS
- Targeted CEA CAR-T CI watch — Atom
- Targeted CEA CAR-T CI watch — JSON
- Targeted CEA CAR-T alone — RSS
Cite this brief
Drug Landscape (2026). Targeted CEA CAR-T — Competitive Intelligence Brief. https://druglandscape.com/ci/targeted-cea-car-t. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing